New CEO for Welsh neuroscience start-up Draig 

Neuroscience start-up Draig Therapeutics Ltd. has chosen Ivana Magovčević-Liebisch to be its president and CEO. She joins the Welsh start-up after founding and serving as president and CEO of Vigil Neuroscience Inc., which Sanofi (Euronext:SAN; NASDAQ:SNY) acquired this year. Draig co-founder Ruth McKernan, an operating partner at SV Health Investors, had been interim president and CEO, and will remain on its board. Draig emerged from stealth mode in June with $140 million in funding, including seed capital from SV Health.

Slingshot Therapeutics Ltd., the Syncona accelerator, rounded out its executive team by hiring John Isaac as CSO and Bobby Soni as CBO. Isaac, who most recently was CSO at AviadoBio Ltd., previously served as head of neuroscience, external innovation, EMEA at Johnson & Johnson Innovation. Soni was CBO of the BioInnovation Institute, which Syncona said is Europe’s largest bioscience accelerator. Founding CSO Richard Wooster will move to a non-executive role as scientific adviser and board member. Syncona launched the accelerator last year to identify, de-risk and develop therapies from the work of academic researchers...